Saltar al contenido
Merck

Surface Hydration Protects Cystic Fibrosis Airways from Infection by Restoring Junctional Networks.

Cells (2022-05-15)
Juliette L Simonin, Alexandre Luscher, Davide Losa, Mehdi Badaoui, Christian van Delden, Thilo Köhler, Marc Chanson
RESUMEN

Defective hydration of airway surface mucosa is associated with recurrent lung infection in cystic fibrosis (CF), a disease caused by CF transmembrane conductance regulator (CFTR) gene mutations. Whether the composition and/or presence of an airway surface liquid (ASL) is sufficient to prevent infection remains unclear. The susceptibility to infection of polarized wild type and CFTR knockdown (CFTR-KD) airway epithelial cells was determined in the presence or absence of a healthy ASL or physiological saline. CFTR-KD epithelia exhibited strong ASL volume reduction, enhanced susceptibility to infection, and reduced junctional integrity. Interestingly, the presence of an apical physiological saline alleviated disruption of the airway epithelial barrier by stimulating essential junctional protein expression. Thus, rehydrated CFTR-KD cells were protected from infection despite normally intense bacterial growth. This study indicates that an epithelial integrity gatekeeper is modulated by the presence of an apical liquid volume, irrespective of the liquid's composition and of expression of a functional CFTR.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
3-Isobutil-1-metilxantina, ≥99% (HPLC), powder
Sigma-Aldrich
Forskolina, from Coleus forskohlii, ≥98% (HPLC), powder
Sigma-Aldrich
Seroalbúmina bovina, heat shock fraction, pH 7, ≥98%
Roche
cOmplete, Mini Protease Inhibitor Cocktail, Tablets provided in EASYpacks
Sigma-Aldrich
CFTR Inhibitor II, GlyH-101, CFTR Inhibitor II, GlyH-101, CAS 328541-79-3, is a cell-permeable potent, selective and reversible open-channel blocker of CFTR (Ki = 4.3 µM in CFTR-expressing FRT cells).
Sigma-Aldrich
Amiloride, Hydrochloride, An inhibitor of angiogenesis.